ANTAGONISM OF THE EFFECTS OF THE HALLUCINOGEN DOM AND THE PURPORTED 5-HT AGONIST QUIPAZINE BY 5-HT2 ANTAGONISTS
ANTAGONISM OF THE EFFECTS OF THE HALLUCINOGEN DOM AND THE PURPORTED 5-HT AGONIST QUIPAZINE BY 5-HT2 ANTAGONISTS
复制标题
DOI:
10.1016/0014-2999(83)90464-8
复制
发表时间:
1983-01-01
影响因子:
5
通讯作者:
ROSECRANS, JA
中科院分区:
文献类型:
--
作者:
GLENNON, RA;YOUNG, R;ROSECRANS, JA
Rats trained to discriminate 1.0 mg/kg of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM) from saline in a 2-lever operant choice task were administered doses of mescaline, LSD, 5-methoxy-N,N-dimethyltryptamine (5-OMe DMT), quipazine, TFMPP [N-(3-trifluoromethylphenyl)piperazine] and RU-24969 [5-methoxy-3-(1,2,5,6-tetrahydropyridinyl)indole]. The DOM-stimulus generalized to the 3 hallucinogenic agents and to quipazine, but not to the purported serotonin agonists TFMPP or RU-24969. Pretreatment of the animals with the 5-HT2 antagonists ketanserin and pirenperone antagonized the effect produced by DOM. Pirenperone blocked DOM-stimulus generalization to mescaline, LSD, 5-OMe DMT and quipazine. The discriminative stimulus effects of DOM, the 3 hallucinogenic agents to which DOM-stimulus generalization occurred and quipazine, may involve those sub-populations of serotonin receptors that are labeled by tritiated ketanserin (i.e., 5-HT2 sites).